| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Director | Jun 02, 2023 | Sale | $23.01 | 8,638 | 198,760 | 40,493 | Jun 02, 2023, 06:15 PM | |
| MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Director | Jun 06, 2022 | Sale | $19.25 | 6,424 | 123,673 | 33,980 | Jun 06, 2022, 07:20 PM | |
| MYGN | MYRIAD GENETICS INC | SPIEGELMAN DANIEL K | Director | May 28, 2021 | Sale | $28.99 | 7,142 | 207,023 | 13,420 | Jun 01, 2021, 07:15 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 30, 2019 | Option Exercise | $68.78 | 176 | 12,106 | 47,686 | Jun 07, 2019, 06:51 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 01, 2019 | Sale | $89.00 | 13,473 | 1,199,097 | 47,510 | Apr 03, 2019, 01:17 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 27, 2019 | Sale | $90.00 | 100 | 9,000 | 60,983 | Mar 29, 2019, 06:19 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 22, 2019 | Option Exercise | $88.05 | 3,598 | 316,804 | 61,083 | Mar 26, 2019, 08:30 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 15, 2019 | Option Exercise | $94.53 | 7,227 | 683,168 | 55,311 | Mar 19, 2019, 08:43 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 01, 2019 | Option Exercise | $94.76 | 912 | 86,421 | 62,538 | Mar 05, 2019, 08:08 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Oct 31, 2018 | Option Exercise | $68.78 | 175 | 12,037 | 51,245 | Dec 20, 2018, 06:06 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 22, 2018 | Sale | $99.00 | 10,000 | 990,005 | 51,542 | Jun 26, 2018, 08:31 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 30, 2018 | Option Exercise | $68.78 | 167 | 11,487 | 62,781 | Jun 06, 2018, 08:15 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 04, 2018 | Option Exercise | $92.07 | 1,711 | 157,532 | 61,070 | Jun 06, 2018, 08:15 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 22, 2018 | Option Exercise | $81.36 | 3,598 | 292,733 | 73,587 | Apr 27, 2018, 07:32 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 23, 2018 | Sale | $82.15 | 11,059 | 908,497 | 62,543 | Apr 25, 2018, 08:37 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 22, 2018 | Option Exercise | $81.36 | 3,583 | 291,513 | 73,602 | Mar 26, 2018, 08:08 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 15, 2018 | Option Exercise | $83.57 | 3,815 | 318,820 | 64,705 | Mar 19, 2018, 09:45 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 02, 2018 | Option Exercise | $79.86 | 1,609 | 128,495 | 68,520 | Mar 06, 2018, 08:48 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 27, 2015 | Sale | $98.90 | 68,156 | 6,740,969 | 109,663 | Oct 13, 2017, 08:43 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Sep 24, 2017 | Option Exercise | $3.94 | 594 | 2,340 | 21,006 | Sep 26, 2017, 05:22 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Jun 24, 2017 | Option Exercise | $3.78 | 2,265 | 8,562 | 19,225 | Jun 27, 2017, 05:41 PM | |
| CASC | Cascadian Therapeutics, Inc. | SPIEGELMAN DANIEL K | Director | Jun 12, 2017 | Option Exercise | $3.34 | 537 | 1,794 | 12,432 | Jun 13, 2017, 04:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 02, 2017 | Option Exercise | $90.72 | 1,801 | 163,387 | 23,303 | Jun 06, 2017, 09:07 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 15, 2017 | Option Exercise | $91.50 | 1,722 | 157,563 | 25,104 | May 17, 2017, 06:50 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 28, 2017 | Option Exercise | $70.30 | 155 | 10,897 | 26,826 | May 17, 2017, 06:50 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 15, 2017 | Option Exercise | $92.50 | 4,301 | 397,843 | 16,460 | Mar 17, 2017, 06:30 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 16, 2017 | Sale | $91.96 | 1,989 | 182,908 | 14,471 | Mar 17, 2017, 06:30 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 06, 2017 | Sale | $93.32 | 2,303 | 214,916 | 20,761 | Mar 08, 2017, 07:28 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 03, 2017 | Option Exercise | $93.95 | 2,283 | 214,488 | 23,064 | Mar 07, 2017, 06:38 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Feb 28, 2017 | Sale | $78.55 | 60,000 | 4,713,000 | 60,347 | Mar 02, 2017, 06:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 01, 2017 | Sale | $94.50 | 5,000 | 472,500 | 25,347 | Mar 02, 2017, 06:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jan 09, 2017 | Sale | $90.00 | 5,000 | 450,000 | 18,100 | Jan 10, 2017, 04:50 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Oct 31, 2016 | Option Exercise | $68.44 | 156 | 10,677 | 43,100 | Nov 14, 2016, 02:02 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Nov 09, 2016 | Sale | $90.61 | 20,000 | 1,812,206 | 23,100 | Nov 14, 2016, 02:02 PM | |
| RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Sep 01, 2016 | Option Exercise | $32.00 | 3,487 | 111,584 | 2,250 | Sep 02, 2016, 12:38 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Aug 01, 2016 | Sale | $99.33 | 4,000 | 397,320 | 42,944 | Aug 03, 2016, 10:19 AM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 06, 2016 | Sale | $89.14 | 1,649 | 146,992 | 46,944 | Jun 08, 2016, 08:39 PM | |
| RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Jun 07, 2016 | Sale | $19.31 | 1,013 | 19,562 | 1,237 | Jun 08, 2016, 05:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 03, 2016 | Option Exercise | $90.00 | 1,801 | 162,090 | 48,593 | Jun 07, 2016, 11:00 AM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 31, 2016 | Sale | $67.12 | 37,737 | 2,533,084 | 71,235 | Jun 02, 2016, 06:21 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 27, 2016 | Option Exercise | $89.09 | 4,305 | 383,532 | 54,339 | May 31, 2016, 06:56 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 23, 2016 | Sale | $87.07 | 3,769 | 328,184 | 58,644 | May 25, 2016, 02:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 29, 2016 | Option Exercise | $51.26 | 202 | 10,355 | 64,135 | May 17, 2016, 03:12 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 13, 2016 | Option Exercise | $82.71 | 1,722 | 142,427 | 62,413 | May 17, 2016, 03:12 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 03, 2016 | Option Exercise | $89.57 | 2,395 | 214,520 | 47,293 | Mar 07, 2016, 08:46 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Feb 29, 2016 | Option Exercise | $81.87 | 46,766 | 3,828,733 | 54,311 | Mar 02, 2016, 08:37 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 02, 2016 | Sale | $86.12 | 4,623 | 398,120 | 49,688 | Mar 02, 2016, 08:37 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Nov 16, 2015 | Option Exercise | $71.68 | 40,000 | 2,867,120 | 48,229 | Nov 18, 2015, 04:03 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 13, 2015 | Option Exercise | $3.88 | 4,011 | 15,563 | 52,675 | Jun 16, 2015, 05:00 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 04, 2015 | Option Exercise | $120.46 | 1,801 | 216,948 | 29,878 | Jun 08, 2015, 06:09 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 05, 2015 | Sale | $122.30 | 1,649 | 201,669 | 28,229 | Jun 08, 2015, 06:09 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 01, 2015 | Sale | $124.16 | 3,945 | 489,811 | 31,679 | Jun 03, 2015, 08:27 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 29, 2015 | Option Exercise | $125.73 | 5,883 | 739,644 | 37,202 | Jun 03, 2015, 08:27 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 18, 2015 | Sale | $130.00 | 34,078 | 4,430,140 | 41,507 | May 28, 2015, 05:10 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 30, 2015 | Option Exercise | $51.26 | 88 | 4,511 | 79,366 | May 19, 2015, 07:25 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 15, 2015 | Option Exercise | $122.78 | 1,722 | 211,427 | 77,644 | May 19, 2015, 07:25 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 18, 2015 | Sale | $124.77 | 2,059 | 256,906 | 75,585 | May 19, 2015, 07:25 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 26, 2015 | Buy | $1.59 | 10,000 | 15,856 | 40,644 | Apr 02, 2015, 05:11 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 25, 2015 | Buy | $1.63 | 10,000 | 16,271 | 30,644 | Apr 02, 2015, 05:11 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 25, 2015 | Buy | $1.63 | 10,000 | 16,271 | 30,644 | Apr 01, 2015, 07:28 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 26, 2015 | Buy | $1.59 | 10,000 | 15,856 | 40,644 | Apr 01, 2015, 07:28 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 02, 2015 | Option Exercise | $73.03 | 31,000 | 2,263,930 | 84,176 | Mar 04, 2015, 07:48 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 18, 2013 | Option Exercise | $61.43 | 14 | 860 | 68,690 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Sep 03, 2014 | Sale | $69.77 | 18 | 1,256 | 68,742 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Oct 30, 2013 | Option Exercise | $66.07 | 9 | 595 | 68,752 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 20, 2013 | Option Exercise | $61.74 | 9 | 556 | 68,699 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Nov 20, 2013 | Option Exercise | $65.89 | 8 | 527 | 68,760 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jun 19, 2013 | Option Exercise | $58.71 | 18 | 1,057 | 68,717 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 05, 2014 | Sale | $82.93 | 12 | 995 | 68,748 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Sep 10, 2013 | Option Exercise | $70.17 | 15 | 1,053 | 68,732 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 02, 2014 | Sale | $58.57 | 11 | 644 | 68,745 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Oct 04, 2013 | Option Exercise | $74.07 | 5 | 370 | 68,737 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Aug 06, 2014 | Option Exercise | $62.17 | 14 | 870 | 68,751 | Feb 10, 2015, 12:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Oct 07, 2013 | Option Exercise | $74.84 | 6 | 449 | 68,743 | Feb 10, 2015, 12:57 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Feb 20, 2013 | Sale | $1.96 | 12,780 | 25,054 | 24,047 | Oct 08, 2014, 04:49 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jul 10, 2013 | Sale | $1.72 | 3,403 | 5,854 | 20,644 | Oct 08, 2014, 04:49 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Sep 02, 2014 | Option Exercise | $54.45 | 32,000 | 1,742,274 | 84,676 | Sep 03, 2014, 06:48 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Aug 01, 2014 | Sale | $61.76 | 2,229 | 137,652 | 68,676 | Aug 04, 2014, 04:35 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jul 02, 2014 | Sale | $64.00 | 2,229 | 142,656 | 70,905 | Jul 03, 2014, 03:24 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 07, 2014 | Option Exercise | $3.06 | 2,044 | 6,255 | 36,827 | Jun 10, 2014, 07:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 29, 2014 | Option Exercise | $57.50 | 3,792 | 218,040 | 59,334 | Jun 02, 2014, 04:52 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Apr 30, 2014 | Option Exercise | $49.50 | 94 | 4,653 | 64,367 | May 16, 2014, 03:32 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 15, 2014 | Option Exercise | $57.44 | 1,241 | 71,283 | 63,126 | May 16, 2014, 03:32 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Mar 11, 2014 | Option Exercise | $3.65 | 4,838 | 17,659 | 38,871 | Mar 12, 2014, 05:04 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Mar 03, 2014 | Sale | $59.69 | 16,000 | 955,010 | 72,273 | Mar 05, 2014, 04:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Dec 02, 2013 | Sale | $54.60 | 18,000 | 982,813 | 46,950 | Dec 04, 2013, 04:15 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Sep 04, 2013 | Sale | $54.03 | 18,000 | 972,540 | 46,950 | Sep 05, 2013, 06:51 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | Jul 01, 2013 | Sale | $59.78 | 4,066 | 243,063 | 39,983 | Jul 02, 2013, 05:29 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 09, 2013 | Option Exercise | $1.86 | 1,135 | 2,111 | 24,357 | Jun 11, 2013, 05:05 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 29, 2013 | Option Exercise | $64.46 | 4,184 | 269,701 | 42,016 | May 30, 2013, 05:50 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | May 01, 2013 | Option Exercise | $51.74 | 56,000 | 2,897,577 | 61,000 | May 03, 2013, 02:41 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 07, 2012 | Option Exercise | $3.67 | 8,174 | 29,999 | 25,492 | Jun 08, 2012, 03:57 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Jun 03, 2012 | Option Exercise | $3.51 | 2,021 | 7,094 | 17,318 | Jun 05, 2012, 06:34 PM | |
| ONTY | Oncothyreon Inc. | SPIEGELMAN DANIEL K | Director | Dec 04, 2011 | Option Exercise | $6.86 | 1,546 | 10,606 | 19,339 | Dec 07, 2011, 06:44 PM |
Menu